Atorvastatin |
Atorvastatin : Prodrug for HMGCR inhibitor
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
More...
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| HMGCR |
|
|
up to 20 uM
Selectivity
Potency Cellular
In Vitro
HMGCR
Mode of Action: Inhibitor, Prodrug
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/jm800001n
In Vivo Validations
Mouse
Dose: 10 mg/kg (IV), 300 mg/kg (PO)
Route of delivery:
Intravenous, Oral
Systemic clearance:
48 ± 32 ml/min/Kg (IV, Blood)
Organ of interest (O):
Liver
DOI Reference: 10.1021/jm800001n
Negative Control Compounds
3S, 5S-Atorvastatin
Notes: (3S, 5S)-Atorvastatin is an inactive or low-activity stereoisomeric enantiomer and pharmaceutical impurity (known as Atorvastatin EP Impurity E) of the cholesterol-lowering medication Atorvastatin.
Chemical Information
| Molecular Formula | C33H35FN2O5 |
| SMILEs | CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O |
| InChI | InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1 |
| Molecular weight | 558.25 Da |
| AlogP | 6.313600000000008 |
| HBond acceptors | 7 |
| HBond donors | 4 |
| Atoms | 76 |
References
Publications
Cross References
ChEMBL: CHEMBL1487 ChEMBL: CHEMBL1790017 ChEMBL: CHEMBL3349878 ChEMBL: CHEMBL393220 BindingDB: 50011213 BindingDB: 50442868 BindingDB: 22164 BindingDB: 50221993 PDB: 117 PubChem: 17589822 PubChem: 23665101 PubChem: 46902102 PubChem: 60822 PubChem: 60823 PubChem: 656846 PubChem: 70680954 PROTAC-DB: Warhead 123 DrugBank: 01076 ChEBI: 2911 ChEBI: 39548 ChEBI: 50686 ChEBI: 50690 canSAR: CANSAR840349Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.